Kronos Bio Inc reports results for the quarter ended in March - Earnings Summary

Kronos Bio

09/05/2022 13:02

* Kronos Bio Inc  KRON.OQ  reported a quarterly adjusted
loss
of 65 cents​​ per share for the quarter ended in March. The mean
expectation of five analysts for the quarter was for a loss
of 66 cents per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * Kronos Bio Inc's reported EPS for the quarter was a loss
of 65
cents​.
    * The mean earnings estimate of analysts had risen by
about 5.7%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Kronos Bio Inc shares had fallen by 39.4% this quarter and
lost 67.8% so far this year.
    * The company reported a quarterly loss of $36.26 million.
    * Wall Street's median 12-month price target for Kronos Bio
Inc is
$32.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 9 at 12:01 p.m.  ​All
figures in US dollars unless otherwise stated